{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-022087","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-06-30T12:29:53+00:00","discovered_at":"2026-06-30T12:35:02.322819+00:00","generated_at":"2026-06-30T12:35:20.510756+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Moleculin Biotech reports warrant exercise for $2.7M; shares outstanding rise to 7.07M","bullets":["Warrants to purchase 1,361,500 shares exercised, generating gross proceeds of ~$2.7 million.","As of June 29, 2026, common shares outstanding total 7,065,000.","Corporate presentation posted on company website; no material updates disclosed in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-022087","json":"https://secwatch.observer/filing/0001437749-26-022087.json","markdown":"https://secwatch.observer/filing/0001437749-26-022087.md","text":"https://secwatch.observer/filing/0001437749-26-022087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926022087/0001437749-26-022087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926022087/mbrx20260629_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T12:35:20.510756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}